Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price was down 27% during mid-day trading on Wednesday . The company traded as low as GBX 7.38 ($0.10) and last traded at GBX 9.85 ($0.13). Approximately 62,044 shares traded hands during trading, a decline of 74% from the average daily volume of 236,416 shares. The stock had previously closed at GBX 13.50 ($0.18).
Celadon Pharmaceuticals Price Performance
The stock has a market cap of £7.97 million, a P/E ratio of -1.63 and a beta of -0.26. The business’s 50 day moving average price is GBX 18.34 and its two-hundred day moving average price is GBX 23.13. The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 196.67.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Pros And Cons Of Monthly Dividend Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What is a support level?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
